Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan

BACKGROUND: The role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in the pandemic context of coronavirus disease 2019 (COVID-19) continues to be debated. Patients with hypertension, diabetes mellitus, chronic renal failure, cerebro-cardiovascular dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihara, Fumiki, Ohtsu, Hiroshi, Nakai, Michikazu, Tsuzuki, Shinya, Hayakawa, Kayoko, Terada, Mari, Matsunaga, Nobuaki, Yasuda, Satoshi, Ogawa, Hisao, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese College of Cardiology. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989871/
https://www.ncbi.nlm.nih.gov/pubmed/35469713
http://dx.doi.org/10.1016/j.jjcc.2022.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989871/
https://www.ncbi.nlm.nih.gov/pubmed/35469713
http://dx.doi.org/10.1016/j.jjcc.2022.04.001

Ejemplares similares